Delivery Order SPE2DB24D2013-SPE2DB25FCHEP

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $53K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,506.62 firm fixed price delivery order is for the supply of SPRYCEL 100 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,188.64 Firm Fixed Price Delivery Order is for the supply of SPRYCEL 100 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,084.71 firm fixed-price delivery order contract supports the supply of SPRYCEL 50 MG TABLET 60S, a specialty medication, to federal medical facilities. The contract has an ultimate completion date of January 8, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPRYCEL 100 MG TABLET 30S. The contract, valued at $10,645.34, is a firm fixed-price delivery order with a period of performance through November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
This federal contract award, valued at $6,072.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of SPRYCEL 70 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 14, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $10,894.94 fixed-price delivery order is for the supply of SPRYCEL 140MG TAB 30S, a branded pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,006.10 firm fixed price delivery order is for the supply of SPRYCEL 50 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of October 31, 2024 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,374.98 firm fixed-price delivery order is for the supply of SPRYCEL 100 MG TABLET 30S, a medication used in the treatment of certain types of cancer. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $25,877.61, is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of December 20, 2024. This award is not designated as a set-aside contract. In addition to this specific delivery...
This federal contract award, valued at $10,645.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product, to support the DLA's mission of providing medical commodities to the U.S. Armed Forces and other government agencies. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCHEP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,544.39 firm fixed-price delivery order is for the supply of SPRYCEL 100 MG TABLET 30S, a cancer medication, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the U.S. military globally. The contract is not designated as a set-aside.

Generated 4/14/25, 10:41 AM